Acuta Capital Partners’s GH Research GHRS Stock Holding History

Acuta Capital Partners’s Portfolio GHRS Stock Details GHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-244,828	Closed	-$2.9M	–	50
2023 Q2	$2.9M	Buy	244,828 +1,578	+0.6%	+$16.2K	1.97%	19
2023 Q1	$1.94M	Hold	243,250	–	–	1.43%	19
2022 Q4	$2.36M	Hold	243,250	–	–	1.46%	20
2022 Q3	$2.83M	Hold	243,250	–	–	1.22%	23
2022 Q2	$2.43M	Sell	243,250 -176,382	-42%	-$2.29M	1.35%	24
2022 Q1	$7.67M	Hold	419,632	–	–	3.59%	8
2021 Q4	$9.79M	Buy	419,632 +26,382	+7%	+$580K	4.12%	5
2021 Q3	$8.68M	Buy	393,250 +243,250	+162%	+$4.95M	3.06%	8
2021 Q2	$3.26M	Buy	+150,000	New	+$3.06M	1.3%	27

Other funds holding GHRS

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Acuta Capital Partners's GHRS Position: Q3 2023 in Review

Acuta Capital Partners sold out of GH Research (GHRS) in Q3 2023, closing a stake of 244,828 shares — an estimated $2.9M sold.

Acuta Capital Partners first reported a position in GHRS in Q2 2021 and held it in 9 quarters. The position peaked at $9.79M in Q4 2021. 29 funds tracked by Wall St. Rank hold GHRS as of Q3 2023.

Acuta Capital Partners reported no remaining GH Research position as of Q3 2023 after selling out during the quarter.
Acuta Capital Partners sold 244,828 GH Research shares in Q3 2023, an estimated $2.9M.
Acuta Capital Partners first reported a position in GH Research in Q2 2021 and held it in 9 quarters.
Acuta Capital Partners's GH Research position peaked at $9.79M in Q4 2021.
29 funds tracked by Wall St. Rank held GH Research as of Q3 2023.

Based on Acuta Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.